Calretinin is a novel candidate marker for adverse ovarian effects of early life exposure to mixtures of endocrine disruptors in the rat

Hanna Katarina Lilith Johansson, Terje Svingen, Julie Boberg, Paul A Fowler , David Stead, Anne Marie Vinggaard, Panagiotis Filis* (Corresponding Author)

*Corresponding author for this work

Research output: Contribution to journalArticle

2 Citations (Scopus)
3 Downloads (Pure)

Equipment

Aberdeen Proteomics

David Stead (Manager)

Medical Sciences

Research Facilities: Facility

Iain Fraser Cytometry Centre

Andrea Holme (Manager), Linda Duncan (Senior Application Scientist), Ailsa Laird (Technician) & Kate Burgoyne (Technician)

Institute of Medical Sciences

Research Facilities: Facility